Approval · Notice of Compliance 31776 · 2023
REACTINE (10 MG TABLET): Notice of Compliance 31776
Issued October 2, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31776
- Date
- October 2, 2023
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to package labels/Mise à jour des étiquettes de l¿emballage
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE (10 MG TABLET) | Not yet assigned | — |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB